Personal Statement
Sheng Qi is Chair in Pharmaceutics in the School of Pharmacy and Pharmaceutical Sciences at the University of Liverpool. Her research focuses on materials science, drug delivery and formulation development, with over 20 years’ experience in the design of novel materials and dosage forms.

Her work addresses a wide range of clinical and real-world applications, including anti-HIV medicines, antimicrobial surfaces, food and nutritional products, and waterless personal care technologies. Sheng has extensive experience in building collaborations and translating research into clinical, industrial and societal impact, and has led multiple REF impact case studies.

Before joining the University of Liverpool in 2026, she was Associate Dean of Innovation at the University of East Anglia, where she provided strategic leadership in enterprise and innovation activity building, including the development of industrial partnerships and academic spin-outs.

Research Overview
Sheng’s research focuses on advanced pharmaceutical materials and manufacturing technologies to enable improved drug performance, scalable production and personalised medicine. Her work integrates molecular pharmaceutics, formulation development and additive manufacturing to address solubility-limited drugs and complex delivery challenges.
Key areas include the development of solid dispersions and amorphous formulations for bioavailability enhancement, drug-eluting medical devices, such as contact lenses, stents and catheters, and pharmaceutical 3D and 4D printing. Her research also explores additive manufacturing strategies for medicine production and device coating, enabling precise control of drug release and product customisation.
Together, these activities support the translation of innovative dosage forms and medical devices into clinically and industrially viable solutions.